Literature DB >> 11948124

Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas.

Amy L McDoniels-Silvers1, Caramella F Nimri, Gary D Stoner, Ronald A Lubet, Ming You.   

Abstract

PURPOSE: Differential cDNA library screening was performed on 7 human lung adenocarcinomas and 7 human lung squamous cell carcinomas and their corresponding adjacent normal tissues using a human lung cDNA library constructed from the normal bronchoalveolar cells of a 72-year-old male smoker. EXPERIMENTAL
DESIGN: Of the 2758 clones that were differentially expressed between normal and tumor tissues in the preliminary cDNA library screening analysis, 1163 clones were confirmed by dot blot, revealing a confirmation rate of >40%. DNA of confirmed clones was sequenced and was subjected to GenBank Blast searches. RNA expression levels were then individually analyzed by semiquantitative reverse transcription-PCR.
RESULTS: Ninety-two genes/sequences were differentially expressed in adenocarcinomas and/or squamous cell carcinomas compared with their corresponding normal tissues. Several genes were underexpressed by at least 50% in both tumor types such as c-fos, decorin, alpha-2-macroglobulin, platelet endothelial cell adhesion molecule 1, EGR1, and fibronectin. Ribosomal protein S3 was underexpressed only in squamous cell carcinomas, whereas expression of hepatocyte growth factor activator inhibitor type 2, ubiquitin-conjugating enzyme UBC9, and clone 333E23 on chromosome Xq21.1 were altered only in adenocarcinomas. Several genes discovered recently of which the functions are unknown, such as KIAA0728 and KIAA0425, were also differentially expressed in both adenocarcinomas and squamous cell carcinomas of the lung.
CONCLUSIONS: Many of these known and novel genes may be involved in human lung tumorigenesis; therefore, additional characterization is warranted and will be beneficial to the understanding of this deadly disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11948124

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  53 in total

1.  Role of SUMO/Ubc9 in DNA damage repair and tumorigenesis.

Authors:  Stergios J Moschos; Yin-Yuan Mo
Journal:  J Mol Histol       Date:  2006-06-07       Impact factor: 2.611

Review 2.  SUMO: a (oxidative) stressed protein.

Authors:  Marco Feligioni; Robert Nisticò
Journal:  Neuromolecular Med       Date:  2013-09-20       Impact factor: 3.843

3.  Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner.

Authors:  S Zhu; M Sachdeva; F Wu; Z Lu; Y-Y Mo
Journal:  Oncogene       Date:  2009-12-21       Impact factor: 9.867

4.  Identification of an N-terminal truncation of the NF-κB p65 subunit that specifically modulates ribosomal protein S3-dependent NF-κB gene expression.

Authors:  Eric M Wier; Jordan Neighoff; Xin Sun; Kai Fu; Fengyi Wan
Journal:  J Biol Chem       Date:  2012-10-31       Impact factor: 5.157

Review 5.  Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology.

Authors:  Madalina V Nastase; Renato V Iozzo; Liliana Schaefer
Journal:  Biochim Biophys Acta       Date:  2014-02-05

6.  Differential expression of inflammasomes in lung cancer cell lines and tissues.

Authors:  Hui Kong; Yanli Wang; Xiaoning Zeng; Zailiang Wang; Hong Wang; Weiping Xie
Journal:  Tumour Biol       Date:  2015-04-25

7.  miR-411 contributes the cell proliferation of lung cancer by targeting FOXO1.

Authors:  Zhiju Zhao; Limei Qin; Shu Li
Journal:  Tumour Biol       Date:  2015-11-17

8.  Comparison of lung cancer cell lines representing four histopathological subtypes with gene expression profiling using quantitative real-time PCR.

Authors:  Takashi Watanabe; Tomohiro Miura; Yusuke Degawa; Yuna Fujita; Masaaki Inoue; Makoto Kawaguchi; Chie Furihata
Journal:  Cancer Cell Int       Date:  2010-01-21       Impact factor: 5.722

Review 9.  Sumoylation and human disease pathogenesis.

Authors:  Kevin D Sarge; Ok-Kyong Park-Sarge
Journal:  Trends Biochem Sci       Date:  2009-03-11       Impact factor: 13.807

10.  A list of candidate cancer biomarkers for targeted proteomics.

Authors:  Malu Polanski; N Leigh Anderson
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.